Predicting Stable Recombinant Protein Production via Gene Expression Analysis

Solution Overview

Problem

Current methods for recombinant protein production in CHO cells are plagued by instability, leading to significant losses in productivity due to chromosome rearrangements and gene loss, necessitating lengthy cultivation periods for selection, which is time- and cost-inefficient.

Innovation Solution

A method for early identification of suitable candidate cell clones through determining the expression levels of specific genes such as Hist1h2bc, Egr1, Dhfr, Fgfr2, and others, allowing for the selection of clones with stable recombinant protein production without the need for long-term cultivation, using techniques like quantitative RT-PCR to analyze RNA expression levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methodologies are used to ensure stable recombinant protein production, then reliability of production is improved, but time required for cell line selection increases to several months

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies preliminary action by measuring the expression levels of specific marker genes (such as DHFR, GS, and other metabolic pathway genes) in early-stage cell clones before long-term cultivation. This allows prediction of which clones will maintain stable recombinant protein production, enabling selection decisions to be made early without waiting for months of cultivation to confirm stability.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent replaces the time-consuming empirical testing approach (mechanical/cultural method of growing cells for months) with a molecular biology-based measurement system. By using quantitative RT-PCR or similar techniques to measure gene expression levels of specific markers, the system substitutes direct long-term observation with indirect molecular measurement, dramatically reducing selection time while maintaining reliability prediction accuracy.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If long-term cultivation is performed to identify stable cell clones, then reliability of recombinant protein production is improved, but productivity is reduced due to extended development time

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

By performing preliminary measurement of marker gene expression levels in early cell clones, the invention enables prediction of long-term production stability before committing to extended cultivation. This preliminary screening identifies high-potential clones that are then prioritized for further development, accelerating the overall process from clone selection to production-scale protein output.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the measurement parameter from direct observation of protein production stability (which requires months of cultivation) to measurement of gene expression levels of specific metabolic markers. This parameter change allows stability prediction to be made in days rather than months, directly improving the time-to-productivity metric while maintaining reliable selection of stable producing clones.

Inventive Principle:
Principle #35Parameter changes

3Stability of the object's composition

If empirical testing of cell lines is performed over extended periods, then stability of recombinant protein production is confirmed, but costs increase due to time and resource consumption

Engineering Contradiction:
Core Design Contradiction:
Stability of the object's compositionVSLoss of energy

Solution Approach 1:

The patent substitutes the resource-intensive empirical testing system (requiring months of cultivation, media, labor, and facility usage) with a molecular measurement system. By quantifying the expression levels of specific marker genes using techniques like RT-PCR, the invention provides a less resource-consuming method to predict production stability, reducing both time and material costs while confirming stability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent extracts the essential predictive information from the complex long-term cultivation process by focusing on specific marker genes whose expression levels correlate with production stability. Instead of monitoring all aspects of cell behavior over months, the method extracts and measures only the critical molecular indicators (DHFR, GS, and other metabolic gene expressions) that predict outcomes, reducing resource requirements while maintaining predictive accuracy.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the selection of stable cell clones early in the development process, reducing the time and costs associated with long-term cultivation and improving the reliability of recombinant protein production by identifying clones with minimal productivity loss over 10 weeks.

Implementation Method 1

determining the expression levels of specific genes such as Hist1h2bc, Egr1, Dhfr, Fgfr2, and others, allowing for the selection of clones with stable recombinant protein production without the need for long-term cultivation, using techniques like quantitative RT-PCR to analyze RNA expression levels

Methodology Applied
Scientific EffectReverse transcription:

Data Source

PatentUS10913984B2Predicting genetically stable recombinant protein production in early cell line development
Publication Date: 2021.02.09
  • US10913984B2 patent drawing
  • US10913984B2 patent drawing
  • US10913984B2 patent drawing

AI summary

The present invention relates in general to the field of recombinant protein expression. In particular, the present invention relates to a method for selecting a suitable candidate cell clone for recombinant protein expression and to a host cell for recombinant protein expression, the host cell exhibiting artificially modified gene expression of at least one gene selected from the group consisting of: Hist1h2bc, Egrl, BX842664.2/Hist 1h3c, Dhfr, Fgfr2, AC115880.11, Mmp10, Vsnll (optional), CU459186.17, El 30203 B14Rik, Cspg4, C1qtnf1, Foxp2, and Ptpre.